ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

RFA On Natural Inhibitors Role In Prevention Released

April 2, 1982

Advocacy Groups Form Council To Lobby For Cancer Programs To Benefit Minorities

April 28, 1995

ACS To open Key Positions To Competition In Massive “Reorganization for the ‘90’s

August 6, 1993

AIDS Cachexia Drug Stabilizes Body Weight, Muscle Mass

March 29, 2013

Insurers Increasingly Willing To Cover ABMT For Breast Cancer, GAO Finds

June 7, 1996

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

January 27, 2012